Literature DB >> 1804783

Selective reconstitution of T lymphocyte subsets in scid mice.

J Reimann1, A Rudolphi, M H Claesson.   

Abstract

The 'empty' splenic T-cell compartment of young scid mice was partially and selectively reconstituted by low numbers of adoptively transferred congenic (C.B-17, BALB/c) or semi-allogeneic (dm2), but not completely allogeneic (C57BL/6) CD4+ T cells from adult donor mice. Under the same experimental conditions, the CD8+ T-cell compartment of young scid mice could only be reconstituted in scid mice continuously substituted with IL-2. CD4+ T cells engrafted in the spleen of H-2d scid recipients displayed specific, anti-Ad-associated proliferative reactivity. (Semi)allogeneic CD8+ T cells engrafted in spleens of scid recipients showed no anti-host H-2 class I-associated cytotoxic reactivity, i.e., this T-cell compartment was specifically tolerized against host (allo)antigens. Reconstitution of lymph nodes was not observed following transplantation of purified CD4+ or CD8+ T cells. Antigen-specific, cellular immune responses could not be induced in scid mice selectively reconstituted with either CD4+ T cells or CD8+ T cells. Partial reconstitution of the CD4+ T-cell compartment was always associated with the appearance of scid-derived, 'endogenous' IgM-producing B cells. Serum antibodies of scid mice with this T cell-induced B-cell leakiness stained an immature subset of congenic thymocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1804783     DOI: 10.1111/j.1600-065x.1991.tb00617.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  12 in total

1.  In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)-deficient mice induce intestinal inflammation in immunodeficient hosts.

Authors:  S Bregenholt; J Brimnes; M H Nissen; M H Claesson
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 2.  Novel experimental approaches in the study of the immunopathology in inflammatory bowel disease.

Authors:  J Reimann; A Rudolphi; M H Claesson
Journal:  J Mol Med (Berl)       Date:  1995-03       Impact factor: 4.599

3.  Splenic T helper cell type 1 cytokine profile and extramedullary haematopoiesis in severe combined immunodeficient (scid) mice with inflammatory bowel disease (IBD).

Authors:  S Bregenholt; M H Claesson
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

4.  Minimal requirements for murine resistance to infection with Francisella tularensis LVS.

Authors:  K L Elkins; T R Rhinehart-Jones; S J Culkin; D Yee; R K Winegar
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  A role for B cells in resistance to Cryptococcus neoformans in mice.

Authors:  K M Aguirre; L L Johnson
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

6.  T helper cell recognition of muscle acetylcholine receptor in myasthenia gravis. Epitopes on the gamma and delta subunits.

Authors:  A A Manfredi; M P Protti; M W Dalton; J F Howard; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  Lymphocyte engraftment conveys immunity and alters parasite development in scid mice infected with Echinococcus multilocularis.

Authors:  M C Playford; H K Ooi; M Ito; M Kamiya
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

Review 8.  In vivo models of human lymphopoiesis and autoimmunity in severe combined immune deficient mice.

Authors:  T S Barry; B F Haynes
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

9.  Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors.

Authors:  G F Lauritzsen; S Weiss; Z Dembic; B Bogen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

10.  Epitopes on the beta subunit of human muscle acetylcholine receptor recognized by CD4+ cells of myasthenia gravis patients and healthy subjects.

Authors:  L Moiola; P Karachunski; M P Protti; J F Howard; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.